198 results

Getting checked

Posted on 02.05.2022

Predictive genomics: how Europe can tackle the barriers to better prevention

We need to start a conversation now about how to prepare our systems and societies for the changes on the horizon. In the second of a two-part mini-series on predictive genomics, Francesco Floridini examines how Europe can accelerate the transition. I believe technology is no longer the key barrier to unlocking the potential of predictive […]

By Francesco Florindi Strategic Partnerships Manager – Predictive Genomics, Thermo Fisher Scientific

Getting checked

Posted on 28.04.2022

Time to prepare for the revolution in predictive genomics

Predictive genomics can transform healthcare, shifting the focus towards prevention and getting better value for the money we spend. In the first of a two-part mini-series, Francesco Floridini explores this new paradigm in healthcare. Healthcare today is all about treating people who are ill. They experience symptoms, engage with the health system, and receive an […]

By Francesco Florindi Strategic Partnerships Manager – Predictive Genomics, Thermo Fisher Scientific

Cardio

Posted on 22.03.2022

Listening to patients drives innovation in heart health

Advances in cardiac medical technology save lives every day. But how can future innovations meet the needs of today’s patients even more? By engaging not only with clinicians but also with patients and people at risk of cardiovascular events, our sector is ensuring that advances in technology focus on their quality of life. For example, […]

By Virginie Delage Patient Engagement Manager for the Cardiac Rhythm Management & Cardiovascular Diagnostics & Services businesses of Medtronic in Western Europe

shutterstock_322448540
Regulation

Posted on 19.11.2021

EU move on mergers threatens innovation

At first sight, EU policy on mergers and acquisitions might not need to concern patients and frontline healthcare workers too much. However, a subtle shift in the rules on whether two companies can agree to become one could have a profound impact on access to medical innovation. To understand why this might be, it’s important […]

By Aline Lautenberg General Counsel and Director General Legal & Compliance, MedTech Europe

shutterstock_452431111
Cardio

Posted on 13.10.2021

How innovation is transforming stroke care?

Many of us know someone affected by stroke. It is the second leading cause of death globally and results in 50% of survivors being chronically disabled.[1] In Europe, the incident of stroke will have increased by 34% by the middle of the next decade. [2] The impact of stroke The impact on individuals and families […]

By Alenka Brzulja Vice President of Cardiovascular & Specialty Solutions EMEA, Johnson & Johnson Medical Devices Companies

Capture
Cardio

Posted on 27.09.2021

New EU Alliance will put cardiovascular health in the spotlight

Despite significant advances in recent decades to improve cardiovascular care and reduce mortality, the burden of cardiovascular disease (CVD) remains greater than any other disease. A concerted effort is needed to ensure the voices of stakeholders are heard by policymakers and that cardiovascular health is prioritised accordingly. That is why we have come together just […]

By Jean-Luc Lemercier Corporate Vice President Edwards Lifesciences, EMEA, Canada, Latin America and JAPAC & Chair of the Cardiovascular Sector Group of MedTech Europe

MedTechEurope_FF_SMEs_2021
Research & Innovation

Posted on 23.06.2021

MedTech: a partner in building a research-oriented, innovative, and resilient Europe

The medical technology sector welcomes the European Commission’s 3rd edition of the EU Research and Innovation Days (R&I Days). This event could not have come at a more important time, as this year marks the official launch of Horizon Europe, the EU’s most ambitious research and innovation program to date. The response to the Covid-19 […]

By Patrick Boisseau Director Research and Innovation, MedTech Europe

CVD-MTE-Slider
Cardio

Posted on 27.05.2021

The need for an EU Action Plan for better cardiovascular health

Did you know that every day, some 5,000 people die from cardiovascular diseases (CVDs), amounting to 1.8 million deaths every year? This, unfortunately, makes cardiovascular disease – including heart failure, stroke-related atrial fibrillation, heart valve disease and coronary heart disease – the number one killer in Europe.  The COVID-19 pandemic has radically changed the way we […]

By Jean-Luc Lemercier Corporate Vice President Edwards Lifesciences, EMEA, Canada, Latin America and JAPAC & Chair of the Cardiovascular Sector Group of MedTech Europe

shutterstock_71555491
Access

Posted on 15.03.2021

VIP access: a proposal for a new model for embracing healthcare innovation

High-value innovations in care delivery play an essential role in solving the challenges facing Europe’s health system. However, ensuring adoption and uptake of new technology solutions is far from simple. Current reimbursement and access models have served Europe well but are now reaching their limit in ensuring timely patient access to truly cutting-edge technologies and […]

By Lieven Annemans Senior Full Professor of Health Economics at the Faculties of Medicine at Ghent University and Brussels University, Belgium